Tilray Brands, Inc. (TLRY)
| Previous close | 2.4700 |
| Open | 2.3200 |
| Bid | 2.1300 x 100 |
| Ask | 2.2400 x 500 |
| Day's range | 2.0800 - 2.3400 |
| 52-week range | 1.5000 - 3.4000 |
| Volume | |
| Avg. volume | 32,111,696 |
| Market cap | 1.664B |
| Beta (5Y monthly) | 2.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Yahoo Finance Video
Cannabis industry: DEA reclassification is a 'critical first step'
Cannabis stocks are experiencing a surge in Tuesday's afternoon trading session, fueled by an Associated Press report indicating that the US Drug Enforcement Administration is gearing up to reclassify marijuana as a less dangerous drug. Trulieve (TCNNF) CEO Kim Rivers joins Market Domination to provide insight into the potential implications of this news. Rivers acknowledges that the reclassification process has been "a long journey," explaining the various steps and approvals the drug has undergone before reaching this stage. However, she remains hopeful that there will be "an official announcement" from the DEA confirming its agreement with the recommendation to reschedule cannabis, placing it on the same level as Tylenol and codeine. She hails this potential move as "a critical first step for regulatory and policy changes." Rivers adds that the reclassification could facilitate safer banking operations within the cannabis industry, open new pathways for research, and lead to normalization in areas such as taxation. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Angel Smith
- Barrons.com
Tilray, Other Marijuana Stocks Are Rising. The DEA May Reclassify Marijuana.
The DEA will move to reclassify marijuana to recognize the medical uses of cannabis, however, it would not legalize marijuana outright for recreational use, an AP report said.
- Yahoo Finance Video
How cannabis stocks can win big with new policy changes
Cannabis legalization has been an issue on many ballots in the past decade, with several states opening up to recreational use legalization. US Vice President Kamala Harris called on the federal government to move "as quickly as possible" in terms of reclassifying cannabis from its current Schedule I classification. If any efforts are successful in doing so, what would the cannabis market look like and who would stand to benefit the most? Poseidon Co-Founder & Managing Partner Emily Paxhia joins Market Domination to give insight into potential new legislation around cannabis and what investors and consumers alike can expect moving forward. Paxhia outlines the current efforts to change cannabis legislation in the US: "Importantly with cannabis legalization, we have several efforts running down the field. There is the rescheduling efforts, and we are hoping to see something come out of that soon. There's also the continued and loud discussions around banking reform in the legislative branch but we've also introduced a path through the judicial branch working with Boies Schiller Flexner [LLP] to challenge the 2004-2005 case on Raich Vs Gonzales which about the Commerce Clause."She continues by affirming: "Interestingly things that are catalytic that change the volume of capital flowing into the industry are very top down. We hear from investors that are paying attention to these federal reform signals, but what we are also really interested in is the state-to-state catalysts that really actually open up the markets and improve the business fundamentals." For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Nicholas Jacobino
